Cargando…
Retinoblastoma protein expression and its predictors in triple-negative breast cancer
Retinoblastoma protein (Rb) is a product of the RB tumor suppressor gene. Its expression is highly prevalent in luminal breast cancers and is critical to the success of cyclin-dependent kinase (CDK) 4/6 inhibitor therapy. Expression of Rb in triple-negative breast cancer (TNBC), tumors generally ass...
Autores principales: | Patel, Jaymin M., Goss, Andrew, Garber, Judy E., Torous, Vanda, Richardson, Edward T., Haviland, Miriam J., Hacker, Michele R., Freeman, Gordon J., Nalven, Tessa, Alexander, Brian, Lee, Larissa, Collins, Laura C., Schnitt, Stuart J., Tung, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275038/ https://www.ncbi.nlm.nih.gov/pubmed/32550264 http://dx.doi.org/10.1038/s41523-020-0160-4 |
Ejemplares similares
-
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer
por: Tung, Nadine, et al.
Publicado: (2016) -
Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay
por: Desai, Neelam V., et al.
Publicado: (2018) -
PARP inhibition in breast cancer: progress made and future hopes
por: Tung, Nadine, et al.
Publicado: (2022) -
BRCA1/2 testing: therapeutic implications for breast cancer management
por: Tung, Nadine M., et al.
Publicado: (2018) -
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
por: Tung, Nadine, et al.
Publicado: (2010)